Bayer signs strategic alliance with Covance
This article was originally published in Scrip
Executive Summary
Bayer HealthCare has signed a long-term strategic alliance with the CRO Covance for clinical drug development, which involves R&D services related to Phase II-IV clinical studies and central laboratory services.